Peptide Libraray

Ltc-5 [M6R]

General Information

DCTPep ID DCTPep00221

Peptide Name Ltc-5 [M6R]

Sequence GFFGKRKEYFKKFGASFKRRFANLKKRL

Sequence Length 28

UniProt ID Not available

PubChem CID Not available

Origin Synthetic

Type Synthetic peptide

Classification

Cancer therapy related peptides

Activity Information

Cell Line	Disease	Activity	Assay	Testing Time	Literature
K562	Blast phase chronic myelogenous leukemia, BCR-ABL7 positive; Chronic myeloid leukemia	EC50>36 µM	Hoechst 33342 and PI assay	3h	1

Hemolytic Activity Human erythrocytes: 50% Hemolysis>36 µM

Normal (non-cancerous) Cytotoxicity Not available

Target Not available

Affinity Not available

Mechanism Not available

Structure Information

PDB ID Not available

Predicted Structure DCTPep00221

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity Not available

Linear/Cyclic Linear

Disulfide/Other Bond Not available

N-terminal Modification Free

C-terminal Modification Amidation

Other Modification None

Chiral L

Physicochemical Information

Formula C165H256N48O34

Absent amino acids CDHIMPQTVW

Theoretical pI 11.62

Acidic residues 1

Basic residues 11

Polar residues 6

Molecular weight (Average) 3456.15

Molecular weight (Monoisotopic) 3453.98

Common amino acids K

Net charge 10

Instability index (II) 45.2

Aliphatic index 35.00

Grand average of hydropathicity (GRAVY) -0.986

Half Life
30 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).

Extinction coefficients
Ext. coefficient 1490
Abs 0.1% (=1 g/l) 0.431

Amino acid distribution

Literature Information

Literature 1

Pubmed ID 19563807

Title N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins

Doi 10.1016/j.febslet.2009.06.044

Year 2009

Patent

Patent ID Not available

Patent Title Not available

Other Iinformation Not available

Other Published ID Not available